ArticleTrials2022

Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial.

I Russel Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.